Meticulous Research®—a leading global market research company, published a research report titled Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging], Method (ABC, CSA, PAP) Process, Application, End User—Global Forecast to 2031.
According to this latest publication from Meticulous Research®, the global immunohistochemistry market is estimated to reach $4.08 billion by 2031 at a CAGR of 7.2% from 2024 to 2031. The growth of this market can be attributed to various factors, such as the rising prevalence of chronic diseases coupled with the increasing geriatric population, increasing focus on rare diseases, rising awareness regarding early disease diagnosis, increasing R&D expenditure, growing demand for drug discovery & development, rising prevalence of infectious diseases, and the rise in healthcare expenditure.
Furthermore, increasing inclination towards personalized medicine, advancements in genomics and proteomics, and increasing automation in immunohistochemistry are expected to offer growth opportunities. However, stringent technical requirements, regulatory processes, and the availability of alternative technology are major hindrances to the market’s growth.
Key Players
The key players operating in the global immunohistochemistry market are:
• F. Hoffmann-La Roche Ltd (Switzerland)
• Danaher Corporation (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• Eagle Biosciences, Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Cell Signaling Technology, Inc. (U.S.)
• PerkinElmer, Inc. (U.S.)
• Bio SB Inc. (U.S.)
• Biocare Medical, LLC. (U.S.)
• Bio-Genex Laboratories (U.S.)
• CANDOR Bioscience GmbH (Germany)
• Innovex Biosciences Inc. (U.S.)
Immunohistochemistry Market: Future Outlook
The global immunohistochemistry market is segmented by Offering, Method, Process, Application, End User, and Geography. This study also evaluates industry competitors and analyzes the market at the global and regional levels.
By Offering
The market is divided into:
• Consumables (Reagents [Fixation Reagents, Antigen Retrieval, Buffers, Blocking Reagents, Antibodies, Control Reagents, Chromogenic Substrates, and Counterstain], and Other Accessories)
• Equipment (Staining System, Imaging Systems, Slide Scanners, and Tissue Microarrays)
• Services & Software
In 2024, the consumables segment is expected to account for the largest share of the immunohistochemistry market. This segment's dominance is due to advancements in IHC consumables, the advantages offered by IHC kits and reagents, such as reduced time between sample analysis and results, improved access to advanced IHC solutions, and the recurring use of consumables.
By Method
The methods analyzed include:
• Avidin-Biotin Complex
• Polymer-Based Immunohistochemistry
• Catalyzed Signal Amplification (CSA)
• Fluorescyl-tyramide Amplification
• Improved Catalyzed Signal Amplification (iCSA)
• Multi-Staining Immunohistochemistry
• Labeled Streptavidin Biotin (LSAB)
• PAP Method
In 2024, the avidin-biotin complex segment is expected to dominate the market, attributed to its labeling with peroxidase, high affinity for biotin, and resistivity to enzymatic reactions and pH changes.
By Application
Applications include:
• Research Applications (Drug Discovery, Agriculture & Animal Research, Other Applications)
• Clinical Applications (Reproductive Health, Oncology, Infectious Disease, Other Clinical Applications)
In 2024, the clinical applications segment is anticipated to hold the largest market share, driven by the increasing prevalence of chronic diseases, growing awareness of early disease diagnosis, and increasing affordability of advanced IHC solutions among hospitals and diagnostic laboratories.
By End User
End users are categorized into:
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Academic Institutes & Research Centers
• Other End Users
In 2024, the hospitals & diagnostic laboratories segment is projected to lead the market, thanks to the expansion of public and private hospitals, the rising number of healthcare facilities in emerging countries, the availability of well-equipped systems, and the presence of skilled professionals in these settings.
Geographic Review
This research report provides a comprehensive analysis of the market in:
• North America (U.S. and Canada)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East & Africa
Among all regions, Asia-Pacific is expected to register the highest CAGR during the forecast period. The region's growth is attributed to the emerging healthcare landscape, rapid urbanization, the need to manage the growing burden of infectious diseases, accelerated economic growth, and increased investments in enhancing healthcare accessibility and infrastructure.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5967
Key Questions Answered in the Report
• Which are the high-growth market segments based on offerings, method, application, end user, and region/country?
• What was the historical market size for immunohistochemistry globally?
• What are the market forecasts and estimates for the period 2024–2031?
• What are the major drivers, restraints, challenges, opportunities, and trends in the immunohistochemistry market?
• Who are the major players in the global immunohistochemistry market?
• What is the competitive landscape like, and who are the market leaders in the global immunohistochemistry market?
• What are the recent developments in the global immunohistochemistry market?
• What are the different strategies adopted by the major players in the global immunohistochemistry market?
• What are the geographical trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research